Scarica l'app Stockscreener
2.97
0.67%
-0.02
Dopo l'orario di chiusura:
3.10
0.13
+4.38%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.99
Aprire:
$2.98
Volume 24 ore:
42,545
Relative Volume:
0.31
Capitalizzazione di mercato:
$95.67M
Reddito:
-
Utile/perdita netta:
$-12.48M
Rapporto P/E:
-7.6154
EPS:
-0.39
Flusso di cassa netto:
$-7.93M
1 W Prestazione:
-1.33%
1M Prestazione:
-8.90%
6M Prestazione:
+2.77%
1 anno Prestazione:
-14.41%
Intervallo 1D:
$2.93
$3.07
Intervallo di 1 settimana:
$2.93
$3.20
Portata 52W:
$2.07
$4.20
Anixa Biosciences Inc Stock (ANIX) Company Profile
Nome
Anixa Biosciences Inc
Settore
Industria
Telefono
408-708-9808
Indirizzo
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE
Confronta ANIX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANIX
Anixa Biosciences Inc
|
2.97 | 99.53M | 0 | -12.48M | -7.93M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Anixa Biosciences Inc Stock (ANIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-21 | Iniziato | Maxim Group | Buy |
| 2022-12-23 | Iniziato | Chardan Capital Markets | Buy |
| 2021-04-12 | Iniziato | H.C. Wainwright | Buy |
Anixa Biosciences Inc Borsa (ANIX) Ultime notizie
Real time scanner hits for Anixa Biosciences Inc. explainedWeekly Investment Summary & High Conviction Buy Zone Alerts - Newser
Visual trend scoring systems applied to Anixa Biosciences Inc.Market Movement Recap & Expert Approved Momentum Ideas - Newser
Exit strategy if you’re trapped in Anixa Biosciences Inc.July 2025 Intraday Action & Low Drawdown Investment Strategies - Newser
Price momentum metrics for Anixa Biosciences Inc. explained2025 Earnings Surprises & Reliable Entry Point Trade Alerts - Newser
Using economic indicators to assess Anixa Biosciences Inc. potentialJuly 2025 PostEarnings & Reliable Price Breakout Alerts - Newser
Does Anixa Biosciences Inc. show high probability of reboundJuly 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - Newser
Analyzing recovery setups for Anixa Biosciences Inc. investorsJuly 2025 Price Swings & High Return Trade Guides - Newser
Will Anixa Biosciences Inc. outperform during market ralliesRisk Management & Low Risk Growth Stock Ideas - khodrobank.com
Can technical indicators confirm Anixa Biosciences Inc.’s reversalJuly 2025 Price Swings & Verified Momentum Stock Alerts - Newser
Leading Cancer Treatment Biotech Anixa Biosciences Set for Key Presentation at Global Investment Conference - Stock Titan
Top chart patterns to watch in Anixa Biosciences Inc.Bond Market & AI Powered Market Trend Analysis - Newser
Can Anixa Biosciences Inc. expand into new marketsWeekly Profit Recap & Low Drawdown Trading Techniques - khodrobank.com
What’s the beta of Anixa Biosciences Inc. stockM&A Rumor & Accurate Intraday Trading Signals - khodrobank.com
Is Anixa Biosciences Inc. still worth holding after the dip2025 Market Trends & Scalable Portfolio Growth Methods - Newser
Anixa Biosciences (NASDAQ:ANIX): Assessing the Feasibility of Sustained Growth Amid Rising Cash Burn - AInvest
Assessing Anixa Biosciences' (NASDAQ:ANIX) Cash Burn and Cash Runway - AInvest
Here's Why We're Not Too Worried About Anixa Biosciences' (NASDAQ:ANIX) Cash Burn Situation - Yahoo Finance
Applying sector rotation models to Anixa Biosciences Inc.2025 Risk Factors & Trade Opportunity Analysis Reports - Newser
Is Anixa Biosciences Inc. forming higher highs and higher lows2025 Sector Review & Technical Entry and Exit Tips - khodrobank.com
Technical analysis overview for Anixa Biosciences Inc. stockMarket Performance Recap & Low Risk Growth Stock Ideas - Newser
Anixa Biosciences Inc. recovery potential after sell off2025 Price Action Summary & Smart Investment Allocation Tips - Newser
Applying Wyckoff theory to Anixa Biosciences Inc. stock2025 Support & Resistance & Long-Term Growth Stock Strategies - Newser
ANIX Gets New Patent for Breast Cancer Vaccine Technology, Stock Up - MSN
How to interpret RSI for Anixa Biosciences Inc. stockBull Run & Technical Pattern Recognition Alerts - Newser
Anixa Biosciences Inc. Shows Support at Fibonacci Level getLinesFromResByArray error: size == 0 - thegnnews.com
Volatility clustering patterns for Anixa Biosciences Inc.Risk Management & Precise Entry and Exit Recommendations - Newser
Can a trend reversal in Anixa Biosciences Inc. lead to recoveryWeekly Trend Report & Safe Swing Trade Setups - Newser
Price Channel Expanding on Anixa Biosciences Inc.’s Chart getLinesFromResByArray error: size == 0 - newsyoung.net
Anixa Biosciences Inc Azioni (ANIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Anixa Biosciences Inc Azioni (ANIX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| KUMAR AMIT | Chief Executive Officer |
Jul 30 '25 |
Buy |
3.16 |
5,000 |
15,800 |
579,925 |
| Baskies Arnold M | Director |
Jul 18 '25 |
Buy |
3.39 |
5,000 |
16,950 |
125,000 |
| Titterton Lewis H jr | Director |
Jul 11 '25 |
Buy |
3.14 |
10,000 |
31,400 |
943,334 |
| KUMAR AMIT | Chief Executive Officer |
Jul 11 '25 |
Buy |
3.15 |
5,000 |
15,750 |
574,925 |
| KUMAR AMIT | Chief Executive Officer |
Jun 04 '25 |
Buy |
2.85 |
10,000 |
28,500 |
569,925 |
| Baskies Arnold M | Director |
Jan 28 '25 |
Buy |
2.82 |
5,000 |
14,100 |
120,000 |
| Titterton Lewis H jr | Director |
Jan 23 '25 |
Buy |
2.91 |
2,000 |
5,820 |
932,334 |
| Titterton Lewis H jr | Director |
Jan 24 '25 |
Buy |
3.00 |
1,000 |
3,000 |
933,334 |
| Titterton Lewis H jr | Director |
Jan 22 '25 |
Buy |
3.01 |
2,000 |
6,020 |
930,334 |
| Titterton Lewis H jr | Director |
Jan 21 '25 |
Buy |
2.59 |
6,000 |
15,540 |
928,334 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):